
LaNoReC Study
@lanorecstudy
International prospective registration study: standardised MRI review, radiotherapy and selective LLND for lateral nodal disease in rectal cancer
ID: 1326202212956123136
10-11-2020 16:37:11
32 Tweet
125 Followers
32 Following



Vacature PhD kandidaat: per 1 juni 2022 zoeken wij een enthousiaste basis-arts om onze team te versterken! Je gaat aan de slag met de grootste landelijke Snapshot studie over rectumcarcinoom en het opstarten van de LaNoReC studie. Interesse? Mail: [email protected]



.Hidde Kroon gives a bleeding edge update on management of LPLND in rectal cancer. #RACS23 RACSurgeons


15 to 20% local recurrence rate if lateral nodes > 7mm are left behind after CRTx for rectal cancer. Miranda Kusters Significantly lower if dissected. Response to CRTx may not be enough. #RACS23


Inspirational start to colorectal section at #RACS23 with masterclass on lateral lymph node dissection with Hidde Kroon Miranda Kusters and James Ngu. Great program from Tarik Sammour & Tiong Sia



Update @LaNoReCstudy: the study has become a registration study, not subject to ethical restrictions, open for ALL patients with enlarged (≥7.0mm) or intermediate (5.0-6.9mm) lateral nodes with ANY neoadjuvant treatment, with a new protocol. Keen to join? [email protected]


Adequate coverage of lateral lymph nodes by routine radiotherapy is associated with considerable lateral local recurrence risk. Published in #RedJournal #laterallymphnodes #colorectalresearch #radiotherapy Tania Sluckin Sanne Hazen Miranda Kusters sciencedirect.com/science/articl…



The renewed Dutch delineation guideline has been approved by the Dutch GI radiotherapy association (LPRGE)! This guideline will guarantee uniform delineation and coverage of lateral lymph nodes in the LaNoReC study. Want to join the next online training? [email protected]



Neoadjuvant (C)RT is essential for those with enlarged LLNs. Expert radiologists have renewed the LPRGE guideline, and will discuss this guideline in a training sessions with a training case on the 24th of November at 08.00 (UTC+1). Interested? Mail: [email protected]

The LaNoReC is currently recruiting in 13 centers and the first 7 patients have been included in the main arm, and another 5 patients have been included in the registration arm! Want to join? Mail: [email protected]


Lateral lymph nodes during the European Society of Surgical Oncology (ESSO) 142 conference! On Thursday 26th of October the prognostic implications of the number of lateral lymph nodes and their malignant features were discussed.


On 21-11 Tania Sluckin obtained her doctoral degree by defending her thesis entitled "lateral lymph nodes in rectal cancer". This thesis stresses the importance of adequate treatment of lateral lymph nodes and the LaNoReC trial. Want to receive a PDF? Mail [email protected]


